Rouvax Measles vaccine

País: Nova Zelândia

Língua: inglês

Origem: Medsafe (Medicines Safety Authority)

Ingredientes ativos:

Measles vaccine 1000 TCID50

Disponível em:

Seqirus (NZ) Ltd

DCI (Denominação Comum Internacional):

Measles vaccine 1000 TCID50

Dosagem:

1000 TCID50

Forma farmacêutica:

Suspension for injection

Composição:

Active: Measles vaccine 1000 TCID50 Excipient: Alanine Arginine hydrochloride Asparagine Aspartic acid Cysteine Cysteine hydrochloride monohydrate Dextran 70 Glutamic acid Glycine Histidine Isoleucine Leucine Lysine hydrochloride Methionine Neomycin sulfate Phenolsulfonphthalein Phenylalanine Proline Serine Sorbitol Threonine Tryptophan Tyrosine Urea Valine Water for injection

Unidades em pacote:

Ampoule, glass, 1 x 0.5 mL, 0.5 mL

Classe:

Prescription

Tipo de prescrição:

Prescription

Fabricado por:

Sanofi Pasteur SA

Resumo do produto:

Package - Contents - Shelf Life: Ampoule, glass, 1 x 0.5 mL - 0.5 mL - 24 months from date of manufacture stored at or below 25°C - Combination pack, 1 x ( powder + diluent ) - 1 dose units - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Combination pack, 10 x ( powder + diluent ) - 10 dose units - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light - Vial, glass, single dose, 1 x 1,000TCID50 - 1 dose units - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light

Data de autorização:

1982-11-04